XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Sep. 30, 2019
Mar. 26, 2022
Dec. 28, 2019
Jul. 01, 2023
Jun. 25, 2022
Impairment charge     $ 5,200,000 $ 3,100,000  
Investment     $ 0    
Gain on investment   $ 4,700,000      
Additional equity investment         $ 500,000
Payments for royalties       400,000  
Inventory write down       292,405 $ 1,454,688
Unrealized gain on equity interest       200,000  
Asset Purchase Agreement [Member]          
Sale of Stock, Description of Transaction As consideration for the transaction, the Company received a 20.0% equity stake in Solos Incorporation (“Solos Inc.”). The Company’s 20.0% equity stake will be maintained until Solos Inc. has raised a total of $7.5 million in equity financing. Based on the price paid for equity by the other 80.0% owners of Solos Inc. and other factors, the Company estimated the fair value of its equity holdings at $0.6 million and in 2019 recorded a $0.6 million gain on its investment for this equity transaction as the basis of assets transferred was zero. The investment was written down to $0.4 million as a result of an impairment analysis and write down performed in 2020.        
Equity Method Investment, Aggregate Cost $ 7,500,000        
Investment Owned, Fair Value 600,000        
Realized Investment Gains (Losses) 600,000        
Investment owned $ 400,000        
Inventory write down       $ 200,000  
Equity Investment [Member]          
Equity investment owned percentage       3.40%